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 1 
INTRODUCTION 
 
Retinal Vasculitis is a group of inflammatory disorders of the eye 
characterised by retinal vascular inflammation along with intra-ocular 
inflammation. It preferentially affects the veins, but rarely arteries or 
arterioles or both veins and arteries can be affected. It is most commonly 
associated with presence of retinal haemorrhages or vitreous 
haemorrhages. Recurrence of vitreous haemorrhages is a common feature 
which might later get complicated by development of retinitis proliferens 
followed by retinal detachment, complicated cataract and ultimately 
secondary glaucoma. Ophthalmoscopic examination and fundus 
fluorescein angiography along with other investigations play a key role in 
the diagnosis and management of retinal vasculitis. 
HISTORICAL ASPECTS 
The first attempt to discuss in detail the clinical syndrome of 
recurrent haemorhages was made by HENRY EALES (1880-82). 
PERLS(1873) and ANGELUCCI(1878) studied the histological 
appearance of periphlebitis. 
 2 
WADSWORTH (1887) was the first to describe the clinical picture 
of perivasculitis. 
AXENFELD and STOCK (1909-11) drew attention to the 
etiological significance of tuberculosis. 
 
Fig 1-HENRY EALES 
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CLASSIFICATION OF RETINAL VASCULITIS 
DUKE ELDER’S CLASSIFICATION1 
1. Vasculitis secondary to uveitis 
2. Vasculitis secondary to systemic diseases 
3. Apparently primary vasculitis 
COGAN’S CLASSIFICATION2 
1. Mild Papillophlebitis 
2. Moderate vasculitis which is bilateral and affects arterioles 
and/or veins 
3. Severe vasculitis- Arterioles involved more than veins 
RECENT CLASSIFICATION
3
 
1. Primary Vasculitis 
2. Vasculitis secondary to systemic diseases 
3. Vasculitis secondary to ocular diseases 
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CLINICAL FEATURES OF RETINAL VASCULITIS 
SYMPTOMS OF RETINAL VASCULITIS- 
3
 
The patient can present with the following ocular symptoms- 
1. Painless loss of vision 
2. Floaters 
3. Scotomata due to areas of ischemia 
4. Less commonly alteration in color vision and 
metamorphopsia 
5. Can be asymptomatic if lesions are involving the retinal 
periphery 
In association to these systemic manifestations may include- 
1. Genital or oral ulcerations 
2. Joint pains 
3. Chest pain and breathlessness 
4. Neurological manifestations 
5. Skin ulcerations 
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SIGNS OF RETINAL VASCULITIS- 
3
 
1. Sheathing of vessels 
2. Obliteration and perivascular edema 
3. Retinal hemorrhages 
4. Occlusive retinopathy characterised by capillary non 
perfusion areas 
5. Vascular architectural alterations like arteriolar/venule 
anastomosis and crossing of vessels across horizontal raphe 
6. Recurrent vitreous haemorrhage 
7. Optic disc edema or optic atrophy 
8. Cystoid Macular Edema 
PATHOGENESIS 
Retinal vasculitis is considered to be an autoimmune phenomena 
wherein the CD4 T cells are responsible for the cell mediated immunity. 
These cells are found both within and surrounding the blood vessels. 
Some studies have demonstrated the role of humoral immunity and 
immune complex deposition too in the occurrence of retinal vasculitis. 
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PRIMARY VASCULITIS 
The cases of retinal vasculitis which are not associated with any 
ocular or systemic diseases are termed as idiopathic retinal vasculitis or 
primary vasculitis. It includes- 
1. Eales Disease 
2. Idiopathic Retinal Vasculitis, Aneurysms and Neuroretinitis 
(IRVAN) 
3. Frosted Branch Angiitis 
4. Scleritis 
EALES DISEASE 
It was first described in 1880 by Henry Eales who described it in 
five young men with recurring vitreal and retinal haemorrhages 
associated with constipation and epistaxis
5
.  
It is an idiopathic, bilateral, asymmetric condition presenting as an 
obliterative perivasculitis
6
. It can affect multiple quadrants of the fundus. 
Mostly it starts at or anterior to the equator and then proceeds towards 
posterior pole. It mostly affects young males between 20-30 years of age.  
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Clinical Features 
Patients may present with painless diminution of vision and 
floaters in both eyes but the involvement is asymmetric. 
There will be no signs in the anterior chamber and presence of cells 
and flare mark the beginning of rubeosis iridis. 
The following features are typical of Eales Disease-
7
 
1. Vascular Sheathing or inflammation (Fig 2) 
2. Retinal capillary non-perfusion which may or may not be 
associated with neovascularisation 
3. Vitreous Hemorrhage (Recurrent) 
4. Cystoid Macular Edema  
          
Fig 2- Sheathing of vessels in Eales Disease 
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Fig 3- Sheathing with haemorrhages in Eales Disease 
1) Inflammation 
It is the commonest manifestation of Eales Disease presenting as 
vascular sheathing especially during early stages of the disease. Sheathing 
can be continuous or segmental with the presentation ranging from thin 
white lines to heavy exudates.
3
 
The inflammation can lead to keratic precipitates , cells and flare in 
anterior chamber, vitreous cells and cystoids macular edema.  
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On fundus fluorescein angiography, the vascular sheathing is seen 
as hyperfluorescence around the vessel wall and staining of vessel wall 
(Fig 6) 
2) Non Perfusion 
Non perfusion can extend from far periphery to the posterior pole 
with the temporal retina most commonly affected. It is present in all 
patients with Eales Disease. Ghost vessels are seen in the non perfused 
areas. At the junction of non- perfused  and perfused retina, 
microaneurysms, arterio-venous shunts and venous beading can be 
visualised
8
. Intra-retinal haemorrhages (Fig 3) occur in the affected area 
followed by venous tortuosity and formation of collaterals. Branch retinal 
vein occlusion is noted in some patients which does not necessarily 
follow the horizontal midline
9
. 
3) Neovascularisation 
Non perfusion leads to formation of new vessels at the disc or 
elsewhere in the retina. Rubeosis iridis has also been reported. It often 
occurs at the junction of perfused and non perfused retina due to over-
expression of Vascular Endothelial Growth  Factor( VEGF).  It is seen as 
leak on FFA(Fig 7). The commonest sequale of neovascularisation is 
 10 
vitreous hemorrhage which in due course progresses to formation of 
fibrous scar tissue ultimately leading to tractional retinal detachment. 
ETIOPATHOGENESIS 
Multiple pathological, immunological, molecular biological and 
biochemical studies have indicated the role of HLA antigen, 
autoimmunity, mycobacterial genome and oxidative stress mechanism in 
the pathogenesis of vasculitis. 
Higher phenotypic association of HLA B5, DR1 and DR4 was seen 
in patients with retinal vasculitis.
10,11
 
Polymerase chain reaction using IS 6110 primers was done to 
detect the bacterial genome in vitreous fluid, epiretinal membrane and 
was statistically found in Eales patients.
11
 
Biochemical studies show that the protein carbonyl group content 
increases with severity of Eales disease, indicating the role of oxidative 
stress in Eales disease.
12
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Fig 4 – Tractional detachment in Eales Disease 
 
Fig 5- Neovascularisation in Eales Disease 
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CLASSIFICATION OF EALES DISEASE- 
32
 
Classification is based on the evolution and progress of the disease. 
The classification divided the disease into four stages 
Stage 1 
Mild periphlebitis of peripheral retinal capillaries 
Stage 2 
Wide spread periphlebitis of the venous system 
Stage 3 
New vessel formation and vitreous hemorrhage 
Stage 4 
End result of multiple hemorrhages –Retinitis proliferans.(Fig 4) 
NEWER CLASSIFICATION 
This new system of classification divides the disease into central 
and peripheral, and peripheral type is further subdivided as 
Stage 1a 
Periphlebitis of small caliber vessels with superficial retinal 
hemorrhages. 
 13 
Stage 1b 
Periphlebitis of large caliber vessels with superficial hemorrhages. 
Stage 2a 
Areas of capillary non-perfusion. 
Stage 2b 
Neovascularization of disc and elsewhere. (Fig 5) 
Stage 3a 
Fibrovascular Proliferation 
Stage 3b 
Vitreous hemorrhage 
Stage -4a 
Traction Or Combined Retinal detachment 
Stage-4b 
Rubeosis iridis, Neovascular glaucoma, cataract and optic atrophy. 
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Fig 6- Vessel wall staining in Fundus Fluorescein Angiography  
in Eales Disease 
 
Fig 7- New vessel leak in Fundus Fluorescein Angiography In Eales 
Disease 
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DIFFERENTIAL DIAGNOSIS- 
17
 
 Diabetes Mellitus 
 Sickle Cell hemglobinopathies 
 Sarcoidosis 
 Systemis Lupus Erythematosus 
 Branch Retinal Vein Occlusion 
 Central Retinal Vein Occlusion 
 Coat’s Disease 
 Pars Planitis 
 Dragged Disc Syndrome 
 Macular Telengiectasia 
 Cytomegalovirus retinitis 
 Behcets Disease 
 Toxocara 
 Toxoplasma 
 Syphilis 
 Lyme’s Disease 
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OTHER ASSOCIATED SYSTEMIC CONDITIONS
13
- 
 Multiple sclerosis 
 Cerebellar ataxia 
 Myelopathy 
 Hemiplegia 
 Stroke 
 Vestibuloauditary dysfunction 
 Internuclear Ophthalmoplegia 
 Internal carotid artery aneurysms 
 Immunological disorders 
MANAGEMENT 
1. Medical Treatment 
Corticosteroids in the form of oral prednisolone (1mg/kg) for acute 
inflammatory stage tapered over 6-8 weeks has to be started or we can 
administer periocular triamnicolone acetonide in the dose of 0.5-1ml 
(40mg/ml) 
 17 
In patients with intolerance to steroids, oral methotrexate 12.5 
mg/week for 12 weeks can be tried. 
Anti tubercular therapy in patients with acute phlebitis with 
massive infiltration, nodule formation and obliteration of segment of 
veins has shown good outcomes. 
2. Laser Photocoagulation 
Laser photocoagulation is effective in stages of non perfusion  
(Fig 9,10) and neovascularisation. Focal, sectoral or panretinal 
photocoagulation can be given using laser indirect ophthalmoscope.  
(Fig 8,11) 
Anchoring photocoagulation is applied at the base of tractional band 
to prevent further combined detachment.
15
 
3. Pars Plana Vitrectomy 
It is indicated in the following scenarios- 
a. Non resolving vitreous haemorrhage(>6-8 weeks) 
b. Tractional Retinal Detachment involving posterior pole 
 18 
 
Fig 8-FFA post laser photocoagulation in Eales’ Disease 
 
Fig 9-Capillary non perfusion areas with vessel wall staining in 
Eales’ Disease 
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Fig 10- Areas of capillary non- perfusion and leaks on FFA  
in Eales Disease 
 
Fig 11-Fundus photo after application of laser photocoagulation to 
areas of leak and non-perfusion 
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c. Multiple vitreous membranes 
d. Combined tractional and rhegmatogenous retinal detachment 
e. Media Opacities 
VISUAL PROGNOSIS 
Inspite of extensive non perfusion, the posterior pole is spared in 
most of the cases preserving a good visual acuity. In cases of vitreous 
hemorrhage, within few weeks to months the hemorrhage settles 
inferiorly and gets re-absorbed restoring normal vision. Progression to 
neovascularisation, non resolving vitreous hemorrhage, retinal 
detachment and neovascular glaucoma can lead to permanent visual 
impairment. 
IDIOPATHIC RETINAL VASCULITIS, ANEURYSMS AND 
NEURORETINITIS (IRVAN SYNDROME) 
It is a rare condition seen in younger individuals. It is characterised 
by the presence of multiple saccular and fusiform aneurysms of the larger 
arterioles along with non perfusion in the periphery with 
neovascularisation, anterior uveitis and optic nerve head swelling. 
 21 
The aneurysms tend to regress and appear at another location 
within a short period of time. 
The disease has been reported in pregnant females with a 
hypercoagulable status.
16
 
Laser photocoagulation in the areas of non perfusion is the current 
treatment of choice. 
FROSTED BRANCH ANGIITIS 
It is usually found in younger individuals who present with a 
sudden diminution of vision. It is characterised by the presence of florid 
translucent retinal perivascular sheathing involving venules more than the 
arterioles, retinal edema and intermediate uveitis. Most of the cases are 
bilateral with males and females showing equal affection. 
Causes of frosted branch angiitis- 
 Idiopathic 
 Tuberculosis 
 Syphilis 
 Herpes Simplex type 2 
 22 
 Ocular toxoplasmosis 
 Influenza A exposure 
 CMV retinitis 
 HIV infection 
 Aseptic meningitis 
 Lymphoma 
 Leukemia 
 Saroidosis 
 Multiple sclerosis 
 Pars Planitis  
 Systemic Lupus erythmatosus 
Patients are responsive to steroids and photocoagulation with good 
visual outcome.
17
 
SCLERITIS 
The vasculature near the scleritis is integrally involved in 
inflammatory and pathological process. The inflammatory reaction in 
anterior scleritis with spill over leading to anterior or intermediate uveitis. 
 23 
Posterior scleritis patients present with severe ocular pain with 
minimal anterior segment changes, minimal vitreous changes, choroidal 
folds and retinal thickening. Ultrasound examination helps in the 
diagnosis. Corticosteroid therapy helps to control the disease. But 
recurrences do occur. Whether Posterior scleritis is associated with a 
systemic disorder must be ruled out. Rheumatological work up should be 
ordered. Many patients respond to corticosteroids but relapse may occur 
on tapering the dose. 
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VASCULITIS SECONDARY TO SYSTEMIC DISEASE 
1.  Secondary to Infectious Disorders 
o Bacterial disorders (Tuberculosis, Syphilis, Brucellosis, Lyme 
Disease) 
o Viral disorders (Cytomegalovirus, Herpes simplex, Varicella 
Zoster, Acquired Immunodeficiency syndrome, Human T cell 
Lymphoma virus) 
o Parasitic disorders (Toxoplasmosis, Toxocara (Fig 27)) 
2.  Secondary to Neurological Disorders 
o Multiple Sclerosis 
o Micro-angiopathy of brain, retina and cochlea (Susac Syndrome) 
3. Secondary to Malignancy 
o Paraneoplastic syndromes 
o Ocular lymphoma 
o Acute Leukemia 
4. Secondary to Systemic Inflammatory Disease- 
o Behcet’s Diseae 
o Sarcoidosis 
 25 
          
Fig 12-Vasculitis secondary to Acquired Immunodeficiency 
Syndrome (OD) 
               
Fig 13- Vasculitis secondary to Acquired  
Immunodeficiency Syndrome (OS) 
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o Systemic Lupus Erythematosus (Fig 14,15,16,17) 
o Wegener’s Granulomatosis 
o Polyarteritis nodosa 
o Churg- Strauss Syndrome 
o Polyarteritis Nodosa 
o Relapsing Polychondritis 
o Rheumatoid Arthritis 
o HLA-B 27 associated uveitis (Fig 24,25) 
o Crohn’ Disease 
o Post vaccination 
o Takayasu’s Arteritis 
o Dermatomyositis 
o Buerger’s Disease 
o Polymyositis 
Retinal Vasculitis Secondary to Tuberculosis-  (Fig 18,19,20,21) 
Vasculitis in tuberculosis infection is very common. It may be 
either due to active systemic infection or due to type IV hypersensitivity 
reaction to tubercular antigen protein.
18
 The inflammation leads to 
periphlebitis and sheathing of vessels with or without haemorrhages. The 
 27 
vessels might get occluded leading to ischemia after few days. It can 
involve any quadrant of retina with presence of sheathing , haemorrhages 
and exudates. The ischemia will further cause formation of new vessels, 
vitreous hemorrhage and tractional retinal detachment. Chest radiograph 
and mantoux test can be employed for preliminary testing. Quantiferon 
TB gold test is more specific.
19
 Once the cause is determined, patient can 
be started on anti- tuberculous therapy and oral corticosteroids with 
regular follow up.  
Vasculitis secondary to Systemic Lupus Erythematosus-  (Fig 
14,15,16,17) 
It’s an immune complex disorder, which affects the eye with severe 
intraocular complication .Ocular involvement is common in the form of 
dryness. 
In 7.5% of the patients with SLE retinal vasculopathy is mostly as 
microangiopathic changes with cotton wool spots. Cotton wool spots and 
retinal hemorrhages correlate with disease activity and are of negative 
prognostic sign. SLE patients with anti-phospholipid syndrome have 
increased risk for retinal vasoocclusive disease.
20
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The pathogenesis of SLE are complex and partially understood, 
include triggering agent such as infection might lead to activation of 
autoreactive T and B cells
21.
 Treatment of microangiopathic changes 
should be chosen in the context of systemic disease. Remission is induced 
with intravenous cyclophosphamide and maintained with other 
immunosuppresants like azathioprine, Mycophenolate Mofetil and 
Rituximab are emerging therapies for SLE. 
HIV Infection- (Fig 12,13) 
The vasculitis in HIV infection can be caused by interaction 
between viral antigen and antibodies which are in the blood circulation. 
Higher the extent of immunosuppresion, more will be the chances of 
developing retinal vasculature involvement. The expression of p24 
antigen over the surface of the virus is associated with advanced stage of 
disease. The patient can have lot of superficial and deep haemorrhages 
along with exudates and vascular sheathing. Finally it may all lead to 
vascular occlusion. Few soft exudates may be noted. Central retinal vein 
occlusion has also been reported.   
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Cytomegalovirus Infection- (Fig 22,23) 
CMV is double stranded DNA virus from Herpes virus family. The 
involvement of retina with CMV infection mostly occurs as an 
opportunistic infection in immunocompromised patients or a congenital 
infection in children. Previously it was mre common with patient who 
have undergone organ transplant but now Acquired Immunodeficiency 
Syndrome is the most common cause when the CD 4 T cell count goes 
below 50 cells per mirolitre.  
The virus reaches the eye through the bloodstream. It can present 
as small, white infiltrates in the retina arund the vessels with flame 
shaped haemorrhages which are scattered throughout along with 
sheathing of vessels. It has another granular variant which has less 
haemorrhages and more of retinal pigment epithium stippling. It starts in 
the periphery and spreads centrally so patients might have no visual 
complaints initially. Anterior chamber involvement is uncommon. All 
patients with a CD 4 count less than 50 should be screened for CMV 
regularly. Once diagnosed, the patients can be started on induction doses 
of intravenous ganciclovir followed by maintenance dose. Other options 
are Foscarnet, Cidofovir , Fomivirsen or Ganciclovir implant. 
 30 
TOXOPLASMOSIS- (Fig 26) 
The causative organism is Toxoplasma Gondii. Man is accidental 
host. Ocular  involvement is very common presenting with characteristic 
chorio-retinitis foci with associated vitritis. Anterior chamber reaction 
may also occur. Old lesions may appear as an atrophic scar. Adjacent to 
the scar reactivation of lesion may occur in many cases. Retinal vasculitis 
may be noticed in some cases presenting as sheathing of vessels. Few 
cases have been reported which had only vasculitis as a presenting feature 
in toxoplasmosis instead of the typical activeretino-choroiditis foci. So, 
toxoplasmosis should be ruled out while evaluating a retinal vasculitis 
case even if typical features are absent. It can be seen in 
immunocompromised patients. Patients can be diagnosed by detecting 
toxoplasma antibodies in the serum. Patient should be started on 
antibiotics with oral corticosteroids. The associated anterior uveitis can be 
treated with topical steroids and cycloplegics. 
VASCULITIS IN MULTIPLE SCLEROSIS 
Multiple sclerosis is a chronic inflammatory demyelinating disease 
of central nervous system mostly affecting young adults.  Ocular 
manifestations include Optic neuritis, Extra ocular muscle disturbance 
and intraocular inflammation. 
 31 
It was reported by Rucker that 20% of patient with Multiple 
sclerosis have vascular sheathing as their association.
22
 
Retinal vasculitis in multiple sclerosis patient is exclusively 
periphlebitis, retinal venous sheathing. It encompasses both the active and 
chronic form. The chronic form of sheathing appears typically as dense 
white strips over several branches of vascular tree. 
Activity of periphlebitis is not correlated with Optic neuritis,  
systemic exacerbation or severity of disease.
23
 It can lead to occlusive 
vasculitis with subsequent formation of neovascularisation. 
BEHCET’S DISEASE 
Ocular Behcet’s is characterized by nongranulomatous uveitis with 
retinal vasculitis. The reported frequency of ocular manifestation is  
83-95% in males and 67-73% in females. 
Retinal vasculitis is of occlusive nature characterized by retinal 
edema, yellowish white exudates and hemorrhages. Behcet’s disease is 
the only systemic vasculitis that affects both arteries and veins and this 
feature is pathognomic of Behcet’s vasculitis.24 Occlusive nature of 
vasculitis will lead to neovascularistion. 
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NECROTIZING VASCULITIS 
Disorder with pathogenesis being linked to antineutrophilic 
cytoplasmic antibodies plus environmental and genetic factors. 
POLYARTERITS NODOSA AND MICROSCOPIC 
POLYANGIITIS 
SYSTEMIC COURSE OF PAN 
 Neuropathy 
 Nephropathy 
 Cutaneous ulcers 
 Gastrointestinal thrombosis and infarction 
 Musculoskeletal pain 
 Coronary arteritis 
 CNS involvement 
OCULAR MANIFESTATION OF PAN 
 Microangiopathy with cotton wool patches 
 Serous Retinal Detachment 
 Retinal Vasculitis 
 33 
 Artery occlusion 
 Ischemic Optic Neuropathy 
CHURG STRAUSS SYNDROME 
 ACR criteria for diagnosis of Churg Strauss Syndrome 
 Asthma, adult onset 
 Eosinopilia >10% in the blood 
 Sinusitis 
 Pulmonary infiltrates 
 Neuropathy 
 Biopsy with vasculitis and Eosinophils 
OCULAR MANIFESTATION 
 Retinal vascular disorders like 
 Ischemic Optic Neuropathy 
 CRAO 
 BRAO 
 CRVO 
 Retinal Vasculitis 
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WEGENER GRANULOMATOSIS 
It’s a triad of Systemic necrotizing vasculitis(87%), necrotizing  
granulomatous involvement of respiratory tract and necrotizing 
glomerulonephritis. 
ACR criteria for diagnosis 
2 of 4 
 Inflammation in the nose and mouth 
 Abnormal urinary sediment 
 Abnormal chest x-ray 
 Granulomatous inflammation of arteries 
OCULAR MANIFESTATION 
 Orbit (13%) 
 Eyelid and Nasolacrimal duct (13%) 
 Episcleritis and Scleritis (11%) 
 Keratitis (8%) 
 Optic neuropathy (6%) 
 Conjunctivitis (4%) 
 Retinal vasculopathy 
 35 
VASCULITIS DUE TO OCULAR DISEASES 
o Pars planitis 
o Choroiditis 
o Posterior uveitis 
o Behcet’s retina sine systemic disease 
o Birdshot retino choroidopathy 
o Acute multifocal hemorrhagic retinal vasculitis 
 
Fig 14-Vasculitis in Systemic Lupus Erythematosus (OD) 
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Fig 15- Vasculitis in Systemic Lupus Erythematosus (OS) 
 
Fig 16-FFA showing staining of vessel walls in SLE 
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Fig 17-FFA showing leaks from NVE in SLE Vasculitis 
 
Fig 18-Sheathing with hemorhhages in vasculitis secondary to 
tuberculosis (OD) 
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Fig 19-Sheathing with haemorrhages in vasculitis secondary to 
tuberculosis (OS) 
 
Fig 20-Vessel wall staining with blocked fluorescence due to 
haemorrhages on FFA(OD) 
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Fig 21-Vessel wall staining with blocked fluorescence due to 
haemorrhages on FFA(OS) 
 
Fig 22-Vasculitis secondary to CMV infection (OD) 
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Fig 23- Vasculitis secondary to CMV infection (OS) 
 
Fig 24-Vasculitis Secondary to Ankylosing Spondylitis 
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Fig 25-FFA showing corresponding areas of leakage from  
NVE  and CNP areas 
 
Fig 26-Toxoplasmosis with accompanying retinal vasculitis 
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Fig 27-Toxocariasis with accompanying retinal vasculitis 
 
 
Fig 28-OCT showing macular edema in case of retinal vasculitis 
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DIAGNOSTIC TESTS IN RETINAL VASCULITIS 
 Complete Blood Count with Differential Count 
 Erythrocyte Sedimentation Rate 
 C- Reactive Protein 
 Renal and Liver Function Test 
 Blood Sugar 
 Urinanalysis 
 VDRL and FTA- ABS test for Syphilis 
 Mantoux Test 
 TORCH Screening 
 ELISA for Toxocara 
 Serum ACE levels 
 ELISA for HIV 
 Rheumatoid Factor 
 Antinuclear antibody 
 Anti DNA 
 Antineutrophil cytoplasmic antibody 
 Antiphospholipid Antibody 
 Human Leukocyte Antigen testing 
 44 
 CSF analysis 
 Vitreous Biopsy 
IMAGING 
 Chest X-Ray 
 Sacro-illiac joint Xray 
 Fundus Fluorescein Angiography 
 Optical Coherence Tomography (Fig 28) 
 B-Scan ultrasonography 
 Magnetic Resonance Imaging 
Role of Fundus Fluorescein Angiography in Retinal Vasculitis 
After making a diagnosis of retinal vasculitis clinically, it is very 
essential to perform Fundus Fluorescin Angiography in eyes with a clear 
media. It helps in making the decision regarding management of the cases 
based on the findings. 
We should look for leakage from the vessel walls and staining 
around the vessel walls which are signs of inflammation. Secondly, we 
should look for any areas of ischemia and capillary drop outs which will 
be seen as hypofluorescent areas which will guide our decision to start 
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laser photo-coagulation and anti –VEGF treatment. Next we should see if 
there are any new vessels which show early hyperfluorescence which 
increases in size and intensity during late phases. There might be 
evidence of macular edema in some cases which will be better visualised 
by optical coherence tomography. Presence of collaterals might be a 
feature in some cases with occlusion of the vessels.  FFA can be repeated 
post laser to look for resolution of leaks from new vessels.  
TREATMENT 
ANTI-INFLAMMATORY 
CORTICOSTEROIDS 
 Systemic route (oral or intravenous administration) 
 Sub-tenon’s injection 
 Intravitreal Triamcinalone 
 Intravitreal implants 
INTRAVITREAL ANTI-VEGF 
IMMUNOMODULATORS 
 Alkylating agents 
 Anti-metabolite 
 T-lympocytes modulators 
 Biological response modifiers. 
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LASER THERAPY 
Pan-retinal photocoagulation 
SURGICAL THERAPY 
Pars plana vitrectomy 
SYTEMIC IMMUNOSUPPRESSANTS 
The mainstay of treatment in vasculitis is either steroids or 
immunosuppressants. In case of an infective etiology, specific treatment 
of the infective agent with or without corticosteroids may be required. 
Anti-Tuberculous Therapy can be started for those testing positive for 
tuberculosis. 
Steroids can be administered either systemically or periocularly. 
For mild to moderate inflammation, subtenon injection of corticosteroids 
(Triamcinolone acetonide 0.5-1ml; 40mg/ml) can be tried 
25
. For 
moderate to severe inflammation oral prednisone in the dose of 1-2 
mg/kg can be started.  Severe cases with posterior pole involvement and 
refractory macular edema can be administered intra-venous 
methylprednisolone and intra-vitreal steroids.
26,27
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For patients who are non-responsive to steroids or steroid 
intolerant, immunosuppresssives can be given. Various drugs used in 
treatment include Methotrexate, Azathioprine, Cyclosporine, 
Mycophenolate Mofetil, Cyclophosphamide and Infliximab. The therapy 
is individualised based on the underlying cause.  
In cases of associated anterior uveitis, topical steroids with 
cycloplegics can be started. 
Laser Photocoagulation and intra-vitreal Anti VEGF injection 
Retinal laser photo-coagulation should be given in cases with 
marked retinal ischemia  with neovascularisation. Intra-vitreal antiVEGF 
can be injected concomitantly to arrest the progression of new vessels. 
Vitrectomy 
For patients with non resolving vitreous hemorrhage, Tractional 
Retinal Detachment and Epiretinal membrane formation.
28
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COMPLICATIONS 
 Cystoid Macular Edema 
 Macular ischemia 
 Vein occlusions 
 Vitreous hemorrhage 
 Tractional Retinal Detachment 
 Rubeosis Iridis 
 Neovascular Glaucoma 
COMPLICATIONS OF ORAL STEROIDS 
FLUIDS, ELECTROLYTES 
 Sodium retention 
 Potassium loss 
 Fluid retention 
 Hypokalemic alkalosis 
 Hyperosmolar coma 
MUSCULOSKELETAL 
 Muscle weakness 
 Steroid myopathy 
 Osteoporosis 
 Aseptic necrosis of femoral and humeral head 
 Tendon rupture 
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GASTROINTESTINAL 
 Nausea 
 Increased appetite 
 Peptic ulcer 
 Perforation of small and large bowel 
 Pancreatitis 
DERMATOLOGIC 
 Poor wound healing 
 Easy brusiability 
NEUROLOGICAL 
 Convulsion 
 Headache 
 Hyperexcitability 
 Moodiness 
 Psychosis 
ENDOCRINE 
 Menstrual irregularities 
 Cushingoid state 
 Suppression of adrenocortical pituitary axis 
 Diabetes 
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OPHTHALMIC 
 Cataract 
 Glaucoma 
 Central serous retinopathy 
 Activation of herpes 
OTHERS 
 Weight gain 
 Thromboembolism 
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AIM OF THE STUDY 
PRIMARY OBJECTIVE 
o To investigate the aetiologies, association with tuberculosis and 
other systemic illnesses 
o Management of retinal vasculitis with either systemic steroids, 
intravitreal anti VEGF , laser photocoagulation , 
immunosuppressants ,vitrectomy or observation based on the case 
scenario  
o Visual outcome following treatment of the vasculitis patient 
SECONDARY OBJECTIVE 
o To look for any complications following treatment  
o Measures to provide rehabilitation for vasculitis patient 
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MATERIALS AND METHODS 
50 cases of retinal vasculitis which attended the vitreo-retina clinic 
of Regional Institute of Ophthalmology and Government Ophthalmic 
Hospital, Egmore , Chennai between August 2015 and August 2016 for a 
period of 1 year were taken up for the study. It is a prospective study. 
INCLUSION CRITERIA 
1.  Age >18 years 
2.  All cases of Retinal Vasculitis presenting with atleast one of the 
following features - 
a.  Sheathing 
b.  Perivascular inflammation 
c.  Superficial and Deep Hemorrhages 
d.  Staining of vessel wall on FFA 
EXCLUSION CRITERIA 
1.  Age <18 years 
2.  Patient with pre existing ocular disease like diabetic retinopathy, 
vein occlusion , arterial occlusion, glaucoma etc 
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METHODOLOGY 
Patient presenting to Retina Clinic were registered, evaluated and 
followed up during the study period. 
A detailed history of the patient, visual acuity assessment, 
intraocular pressure measurement, Slit lamp examination, and fundus 
examination was done. Fundus Fluorescein Angiography and Optical 
Coherence Tomography was done for patients who had atleast one eye 
with clear media. B scan was done for patients without a clear media. All 
patients were subjected to following blood investigations-  
1. Complete hemogram (Hemoglobin, Total WBC Count, Differential 
Count,  Erythrocyte Sedimentation Rate) 
2.  Mantoux Test 
3.  Random Blood Sugar  
4.  VDRL 
5.  Elisa for  HIV 
All cases were referred to the following departments attached to 
Madras Medical College- 
1. Rheumatalogy Clinic 
2. Chest TB clinic 
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3. Dermatology OPD 
4. STD clinic 
5. ENT OPD 
6. Dental OPD 
7. Neurology OPD  
8. Gynaecology OPD (female patients) 
  Patients were managed according to their presentation by either 
conservative treatment or surgical intervention.  
o Patients with peripheral vasculitis and good visual acuity with no 
evidence of retinal non-perfusion were advised periodic 
observation 
o Patients with peripheral vasculitis and good visual acuity and with 
less than 5 DD retinal non-perfusion , systemic steroids  (T. 
Prednisolone 1mg/kg/day)  was started which was tapered 
gradually. 
o Immunosuppressants (Azathioprine 2mg/kg/day) planned for 
resistant cases (not responding to steroids treatment for period of 8  
weeks ) 
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o Patients with peripheral vasculitis with retinal non-perfusion of 
more than 5 DD laser photocoagulation was advised 
o For cases with vitreous hemorrhage, observation and regular follow 
up was advised. 
o For patients with non clearing vitreous hemorrhage and tractional 
retinal detachment vitrectomy with endophotocoagulation was 
advised 
SCREENING PROCEDURES 
o Detailed history of present illness 
o Visual acuity using Snellen’s acuity chart 
o Slit lamp biomicroscopy of anterior segment 
o Intraocular pressure using Goldmann Applanation tonometer 
o Direct and Indirect Ophthalmoscopy  
o Fundus Fluorescin Angiography 
o Optical Coherence Tomography 
o B scan 
o Blood Investigations 
All patients planned for follow up at 1
st
,2
rd
, 4
th
week,3
rd
 month ,6
th
 
month, 9
th
 month, 12
th
 month and the outcomes at the end of 3 months 
were analysed. 
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OBSERVATION AND ANALYSIS 
1. AGE DISTRIBUTION- 
TABLE 1 
AGE GROUP(YEARS) NO.OF CASES PERCENTAGE 
18-28 22 44% 
29-38 21 42% 
39-48 7 14% 
 
            
 
Amongst the 50 case of Retinal vasculitis which visited the retina 
clinic, maximum incidence was in the age group of 18-28 years (44%) 
followed by 29-38 years (42%) followed by 39-48 years (7%). 
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2. SEX DISTRIBUTION 
TABLE 2 
Sex Number Percentage 
Males 40 80% 
Females 10 20% 
 
                  
In our study, incidence of Retinal Vasculitis is more in males 
(80%) as compared to females (20%). Out of the 31 patients with Eales’s 
Disease, 30 were male and only 1 was female. Out of 4 cases with retinal 
vasculitis secondary to ocular disease, 3 were males and 1 was female. 
Out of 15 cases with retinal vasculitis secondary to systemic disease, 7 
were males and 8 were females. 
  
Sex Distribution 
Males
Females
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3. CLASSIFICATION OF RETINAL VASCULITIS 
TABLE 3 
Disease Number Percentage 
Primary Retinal Vasculitis 31 62% 
Retinal Vasculitis Secondary to Systemic 
Disease 
15 30% 
Retinal Vasculitis Secondary to Ocular 
Disease 
4 8% 
             
 
 
 
In our study, cases due to primary retinal vasculitis were maximum 
(62%), followed by those due to systemic diseases (30%) and due to 
ocular disease( 8%). 
  
0%
10%
20%
30%
40%
50%
60%
70%
Primary Retinal
Vasculitis
Retinal Vasculitis
Secondary to
Systemic Disease
Retinal Vasculitis
Secondary to
Ocular Disease
Classification of Retinal Vasculitis 
Percentage
 59 
4. LATERALITY 
TABLE 4 
Eye Number Percentage 
Left 8 16% 
Right 15 30% 
Both 27 54% 
 
              
 
 
In our study, patients had predominant involvement of both the 
eyes (54%) followed by right eye (30%) then left eye (16%). 
 
0%
10%
20%
30%
40%
50%
60%
Left Right Both
Laterality 
Percentage
 60 
5. PRESENTING COMPLAINTS 
TABLE 5 
Presenting Complaints No. Percentage 
Defective Vision 44 88% 
Defective Vision with Floaters 3 6% 
Defective Vision with Redness and Photophobia 1 2% 
Defective Vision with Floaters and Photophobia 1 2% 
Floaters 1 2% 
 
 
In our study, most of the patients presented with complaint of 
defective vision, in few cases associated with floaters, redness and  
photophobia.  
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6. CLINICAL SIGNS- 
TABLE 6 
Clinical Signs 
Primary 
Vasculitis 
Secondary to 
Ocular Disease 
Secondary to 
Systemic Disease 
Sheathing 
13 eyes 
(26.53%) 
3 eyes (75%) 3 eyes (12.5%) 
Sheathing with 
Hemorrhage 
22 eyes 
(44.90%) 
1 eye (25%) 20 eyes (83.33%) 
Hemorrhage 
14eyes  
(28.57%) 
0 (0%) 
1 eye 
(4.17%) 
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In our study, patients with Eales’s Disease mostly presented with 
perivascular sheathing and haemorrhages, those secondary to systemic 
diseases also presented maximally with perivascular sheathing and 
haemorrhages and those secondary to ocular disease had sheathing as the 
predominant finding. Out of the 31 case of Eales Disease, 6 patients had 
vitreous hemorrhage at the time of presentation, 9 patients had associated 
neo-vascularisation, 7 patients had tractional bands and 2 cases were 
complicated with tractional retinal detachment.  
Amongst the 15 cases secondary to systemic diseases, 1 patient had 
vitreous hemorrhage, 3 patients had neo-vascularisation and 3 patients 
had tractional bands. 
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7. BEST CORRECTED VISUAL ACUITY AT 
PRESENTATION- 
TABLE 7 
BCVA Primary Vasculitis 
Secondary to 
Ocular Disease 
Secondary to 
systemic disease 
6/6-6/18 3 eyes (6.12%) 0% 0% 
6/24-6/60 18 eyes (36.73%) 2 eyes (50%) 7 eyes (29.17%) 
<6/60 28 eyes (57.15%) 2 eyes (50%) 17 eyes (70.83%) 
 
 
In our study, in patients with Eales’s Disease, best corrected visual 
acuity at presentation was predominantly less than 6/60 ( 57.15%). In 
patients with vasculitis secondary to ocular disease, best corrected visual 
acuity was equally present in range of 6/24-6/60 and less than 6/60. In 
patients with vasculitis secondary to systemic disease, best corrected 
visual acuity was mostly less than 6/60 (70.83%). 
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8. TREATMENT MODALITY 
TABLE 8 
Treatment 
Modality 
Primary 
Vasculitis 
Secondary to 
Ocular Disease 
Secondary to 
Systemic Disease 
Observation 
12 patients 
(38.71%) 
0% 
4 patients 
(26.67%) 
Steroids 
11 patients 
(35.48%) 
3 patients (75%) 3 patients (20%) 
Laser 
1 patient 
(3.23%) 
0% 0% 
Steroids + Lasers 
7 patients 
(22.58%) 
0% 
2 patients 
(13.33%) 
Treatment specific 
to disease entity 
0% 1 patient (25%) 6 patients (40%) 
 
 
In patients with Eales Disease, those who presented with vitreous 
hemorrhage, tractional retinal detachment, tractional bands and minimal 
sheathing (12 patients) with no capillary non-perfusion areas observation 
was advised. Those patients who had extensive sheathing and 
haemorrhages with capillary non perfusion less than 5 DD (11 patients) 
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were started on T. Prednisolone 1mg/kg/day in tapered dosing. Steroids 
and laser photo-coagulation was the treatment for 7 patients with 
neovascularisation and capillary non-perfusion areas more than 5DD. 
In patients with vasculitis secondary to ocular disease,2 patients 
were secondary to intermediate uveitis and 1 patient with choroiditis were 
started on oral steroids. 1 patient with choroiditis with associated 
tuberculosis was started on anti-tuberculous therapy and oral steroids.  
In patients with vasculitis secondary to systemic disorders, 4 
patients with associated acquired immunodeficiency syndrome were kept 
on observation. 1 patient with associated ankylosing spondylitis and 2 
patients with systemic lupus erythematosus were started on oral steroids. 
1 patient with ankylosing spondylitis and 1 with systemic lupus 
erythematous having neovascularisation  were administered laser photo-
coagulation along with oral steroids. 3 patients secondary to tuberculosis 
were prescribed anti-tuberculous therapy and oral steroids.1 patient with 
associated cytomegalovirus infection was started on IV Ganciclovir with 
oral steroids.1 patient with associated toxocara infection with vasculitis as 
well as anterior uveitis was started on T. Albendazole 15mg/kg/day for 10 
days along with oral steroids and topical steroids with cycloplegics. 1 
patient with associated toxoplasma infection with both vasculitis and 
anterior uveitis was administered T. Bactrim DS along with oral steroids 
and topical steroids and cycloplegics. 
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9. BEST CORRECTED VISUAL ACUITY AFTER 3 MONTHS- 
TABLE 9 
BCVA 
Primary 
Vasculitis 
Secondary to 
Ocular Disease 
Secondary to 
systemic 
disease 
6/6-6/18 5 eyes (10.64%) 4 eyes (100%) 4eyes (18.18%) 
6/24-6/60 24 eyes (51.06%) 0% 11 eyes (50%) 
<6/60 18 eyes (38.30%) 0% 7 eyes (31.82%) 
 
 
In patients with Eales Disease, visual improvement was noted 3 
months post treatment with 10.64% eyes in the range of 6/6-6/18 as 
compared to 6.12%  eyes pre-treatment. In the range of 6/24-6/60, post-
treatment there were 51.06% eyes as compared to 36.73 % pre-treatment. 
Percentage of patients in less than 6/60 range reduced to 38.30% from 
initial 57.15%.   
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In vasculitis secondary to ocular disease, dramatic improvement 
was seen, with 100% patients improving in the range of 6/6-6/18 as 
compared to 0% pre-treatment. 
In vasculitis secondary to systemic disease, patients in the range of 
6/6-6/18 increased to 18.18% compared to nil initially. Patients in the 
range of 6/24-6/60 increased to 50% from initial 29.17%. Patients with 
visual acuity less than 6/60 reduced to 31.82% compared to 70.83% 
initially. 
2 patients were lost to follow up. 
10. COMPLICATIONS- 
5 patients developed weight gain following steroid administration 
and 2 patients complaint of gastritis following oral steroid administration. 
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DISCUSSION AND RESULTS 
             In this study on 77 eyes of 50 retinal vasculitis patients, 31 
cases(62%) were due to Eales Disease , 15 cases (30%) were secondary 
to systemic disease and the remaining 4 cases (8%) were secondary to 
ocular disease.   
          Amongst the 50 case of Retinal vasculitis which visited the retina 
clinic, maximum incidence was in the age group of 18-28 years (44%) 
followed by 29-38 years (42%) followed by 39-48 years (7%). The mean 
age was 30.02 + 12 years.  In a study by Biswas Et al, mean age of 
presentation was found to be 33 + 11. In a study by Donders in 1958 the 
average age for men was 28 years and for women it was 30 years. 
In our study, incidence of Retinal Vasculitis is more in males 
(80%) as compared to females (20%). Out of the 31 patients with Eales’s 
Disease, 30 were male and only 1 was female. Out of 4 cases with retinal 
vasculitis secondary to ocular disease, 3 were males and 1 was female. 
Out of 15 cases with retinal vasculitis secondary to systemic disease, 7 
were males and 8 were females. 
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This male predilection in Eales Disease was supported by Elliot 
AJ:Thirty year observation of patients with Eales disease, in his study 
93% were Male.
29
 
In our study vasculitis secondary to systemic disease showed 
almost equal incidence in males and females. 
In our study, patients had predominant involvement of both the 
eyes (54%) followed by right eye (30%) then left eye (16%). In patients 
with Eales Disease, bilaterality was seen in 18 out of 31 patients 
(58.06%) and unilateral disease was seen in 13 patients (41.93%) 
indicating towards bilateral presentation being more common than 
unilateral presentation.  Duke Elder has reported that 90% patients with 
Eales Disease will have a bilateral presentation as a rule.
1
 
In our study, most of the patients presented with complaint of 
defective vision (88%), in few cases associated with floaters, redness and 
photophobia. In 8 cases the defective vision was attributable to presence 
of vitreous hemorrhage. Out of these 8 cases, 7 were due to Eales Disease 
and 1 was secondary to systemic tuberculosis.   Defective vision with 
floaters was reported in 3 cases (6% of cases) . All 3 patients presented 
with retinal vasculitis secondary to ocular disease. 2 cases had associated 
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intermediate uveitis and 1 had choroiditis secondary to tuberculosis.  2 
patients with retinal vasculitis secondary to systemic toxoplasmosis and 
toxocariasis complaint of redness and photophobia due to associated 
anterior uveitis.  Only 1 case reported only floaters and was diagnosed as 
having Eales Disease. Probably it was in the initial stage of inflammation 
at time of diagnosis. 
In a study by Biswas et al, defective vision was found to be the 
commonest symptom similar to our study. But they reported higher 
incidence of floaters as compared to our study. 
30
 
In our study, patients with Eales’s Disease mostly presented with 
perivascular sheathing and haemorrhages, those secondary to systemic 
diseases also presented maximally with perivascular sheathing and 
haemorrhages and those secondary to ocular disease had sheathing as the 
predominant finding. Out of the 31 case of Eales Disease, 6 patients had 
vitreous hemorrhage at the time of presentation, 9 patients had associated 
neo-vascularisation, 7 patients had tractional bands and 2 cases were 
complicated with tractional retinal detachment.  
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Amongst the 15 cases secondary to systemic diseases, 1 patient had 
vitreous hemorrhage, 3 patients had neo-vascularisation and 3 patients 
had tractional bands. 
In their study, Biswas et al have also reported vascular sheathing as 
the commonest sign. But the study conducted by Saxena et al shows 
vitreous hemorrhage as the commonest sign.
31,32
  In a study by Supanut et 
al also found vascular sheathing as the most common clinical sign 
involving veins more than the arteries
33,34
. 
In our study, in patients with Eales’s Disease, best corrected visual 
acuity at presentation was predominantly less than 6/60 ( 57.15%) 
probably due to association of vitreous hemorrhage and tractional retinal 
detachment in these patients.   
          In patients with vasculitis secondary to ocular disease, best 
corrected visual acuity was equally present in range of 6/24-6/60 and less 
than 6/60. These patients mainly had extensive sheathing with 
haemorrhages. Associated vitritis could be a reason for vision in the range 
less than 6/60.  
          In patients with vasculitis secondary to systemic disease, best 
corrected visual acuity was mostly less than 6/60 (70.83%).  
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         In patients with Eales Disease , those who presented with vitreous 
hemorrhage, tractional retinal detachment, tractional bands and minimal 
sheathing (12 patients) with no capillary non-perfusion areas observation 
was advised. Those patients who had extensive sheathing and 
haemorrhages with capillary non perfusion less than 5 DD (11 patients) 
were started on T. Prednisolone 1mg/kg/day in tapered dosing. Steroids 
and laser photo-coagulation was the treatment for 7 patients with 
neovascularisation and capillary non-perfusion areas more than 5DD.  
Observation was mainstay of treatment in these cases followed closely by 
oral steroids.  
          In patients with vasculitis secondary to ocular disease,2 patients 
were secondary to intermediate uveitis and 1 patient with choroiditis were 
started on oral steroids. 1 patient with choroiditis with associated 
tuberculosis was started on anti-tuberculous therapy and oral steroids.  In 
these cases oral steroids were the mainstay of treatment. In case 
secondary to infectious etiology i.e tuberculosis anti-tuberculous therapy 
was warranted along with steroids. 
In patients with vasculitis secondary to systemic disorders, 4 
patients with associated acquired immunodeficiency syndrome were kept 
on observation . 1 patient with associated ankylosing spondylitis and 2 
patients with systemic lupus erythematosus were started on oral steroids. 
1 patient with ankylosing spondylitis and 1 with systemic lupus 
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erythematous having neovascularisation  were administered laser photo-
coagulation along with oral steroids. 3 patients secondary to tuberculosis 
were prescribed anti-tuberculous therapy and oral steroids.1 patient with 
associated cytomegalovirus infection was started on IV Ganciclovir with 
oral steroids.1 patient with associated toxocara infection with vasculitis as 
well as anterior uveitis was started on T. Albendazole 15mg/kg/day for 10 
days along with oral steroids and topical steroids with cycloplegics. 1 
patient with associated toxoplasma infection with both vasculitis and 
anterior uveitis was administered T. Bactrim DS along with oral steroids 
and topical steroids and cycloplegics. In these case also, oral steroids 
were the main treatment to decrease the inflammation in addition to the 
specific therapy for associated infectious and non-infectious causes which 
was essential to curb the systemic disease. Topical steroids and 
cycloplegics were helpful in treating the associated anterior uveitis in 2 
cases. In the study by Biswas et al, corticosteroids were found to be the 
main treatment modality similar to our study. 
35
 
After a follow up period of 3 months, patients’ visual acuity was 
reviewed. In patients with Eales Disease, visual improvement was noted 3 
months post treatment with 10.64% eyes in the range of 6/6-6/18 as 
compared to 6.12% eyes pre-treatment. In the range of 6/24-6/60, post-
treatment there were 51.06% eyes as compared to 36.73 % pre-treatment. 
Percentage of patients in less than 6/60 range reduced to 38.30% from 
initial 57.15%.   
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In vasculitis secondary to ocular disease, dramatic improvement 
was seen, with 100% patients improving in the range of 6/6-6/18 as 
compared to 0% pre-treatment. 
In vasculitis secondary to systemic disease, patients in the range of 
6/6-6/18 increased to 18.18% compared to nil initially. Patients in the 
range of 6/24-6/60 increased to 50% from initial 29.17%. Patients with 
visual acuity less than 6/60 reduced to 31.82% compared to 70.83% 
initially. 
2 patients were lost to follow up.  
      Complications were noted in a few cases with 5 patients 
developing weight gain following oral corticosteroid administration. But 
we did not switch over to immunosuppresants because patient was 
responding well to oral corticosteroids. Patient was advised occlusion 
therapy .Two patients complaint of gastritis following oral steroid 
administration.  
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CONCLUSION 
         Retinal vasculitis is a challenge for an ophthalmologist both to 
diagnose and to treat. If left untreated it may lead to total loss of vision. 
Ophthalmologist also play an important role in finding out systemic 
diseases in a patient who have no other manifestations apart from 
ophthalmological signs. That aids in timely treatment of the underlying 
cause. For each patient treatment has to be individualised based on their 
findings. A multidisciplinary approach is required in cases with systemic 
involvement. 
In our study, primary vasculitis is the predominant form of 
vasculitis accounting for 62% of the cases. 
         Male predilection is noted with 80% cases being males and 20% 
being females. 
          Most commonly involved age group is between 18-28 years of age 
(44 %). 
          Maximum cases had a bilateral presentation (54%) with defective 
vision being the chief complaint in most of the cases (88%).  
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          Oral corticosteroids were the main modality of treatment in our 
study. Patients treated with laser photo-coagulation did not show 
worsening of signs. Observation was helpful in patients with vitreous 
hemorrhage. Treatment of associated systemic conditions in addition to 
oral corticosteroids showed improvement in visual acuity.    
        Although systemic steroids are efficacious in controlling active 
disease and easily administered, adverse systemic complications is a 
matter of concern. 
Since the time period of the study was short (1 year), we have kept 
3 months as the criteria for assessing the outcome of management. Due to 
referrals to various departments, patients took time to review with us with 
all the work up.  
More long term studies are required to overcome these 
shortcomings.  
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 PROFORMA 
1. NAME  : 
2. AGE/SEX : 
3. IP NO : 
4. ADDRESS: 
5. OCCUPATION: 
6. CHIEF COMPLAINTS: 
A. OCULAR 
          RE                          LE                        Duration 
a. Defective Vision (Distant/Near) 
b. Total loss of vision 
c.  Floaters 
d. Flashes 
e. Positive scotoma 
f. Macropsia/Micropsia/Metamorphopsia 
g. Field defects 
h. Pain  
i. Redness 
B.SYSTEMIC- Joint pains/ rashes/fever/ oral ulcers/genital ulcers/ skin 
lesions/ chest pain cough/ weight loss/ weakness of limbs/others  
 7. PAST HISTORY:  
Diabetes Mellitus/ Hypertension/ Ischemic heart Disease/ 
Tuberculosis/ Bronchial Asthma/ HIV/Syphilis/ skin diseases like 
psoriasis 
Duration: 
8. FAMILY HISTORY: 
9. PERSONAL HISTORY:  
Smoking/ Alcoholism/ Vegetarian/ Non Vegetarian 
10. TREATMENT HISTORY : 
          Medications                                              Surgery 
11. EXAMINATION:         RE                         LE 
Visual Acuity 
Extra Ocular Examination 
Tension 
Lids 
Conjunctiva 
Cornea 
Iris 
Anterior Chamber 
Pupil 
Lens 
Vitreous 
 12.  FUNDUS EXAMINATION:  
 
 
 
   RE                                                                     LE 
13.  CLINICAL DIAGNOSIS  
14.  INVESTIGATIONS  
a.  BP- 
b.  RBS- 
c. Hemoglobin         d.TC                e.DC                             f. ESR 
g.  VDRL                                     
h.  ELISA for HIV 
15. FUNDUS FLUORECEIN ANGIOGRAPHY 
16.  OPTICAL COHERENCE TOMOGRAPHY 
17.  B SCAN: 
18. OTHER SPECIALITY OPINIONS- 
19.  TREATMENT:    
20. FOLLOW UP: 
 KEY TO MASTERCHART 
Sex 
M -  Male 
F -  Female 
Laterality 
B -  Both Eyes 
R -  Right Eye 
L -  Left Eye 
Symptoms 
D - Defective Vision 
F -  Floaters 
R -  Redness 
P -  Photophobia 
Associated Systemic Disorder 
TB -  Tuberculosis 
AIDS -  Acquired Immunodeficiency Syndrome 
SLE - Systemic Lupus Erythematosus 
AS -  Ankylosing Spondylitis 
 CMV -  Cytomegalovirus 
TP -  Toxoplasma 
TC -  Toxocara 
Associated Ocular Condition 
IU -  Intermediate Uveitis 
C -  Choroiditis 
AU -  Anterior Uveitis 
SIGNS 
S -  Sheathing 
H -  Hemorrhage 
Visual Acuity 
HM - Hand Movements 
CFCF -  Counting Fingers 
Diagnosis 
E -  Eales Disease 
O -  Vasculitis secondary to ocular disease 
S -  Vasculitis Secondary to Systemic Disease 
  
 Treatment 
S -  Oral Corticosteroids 
L -  Laser photocoagulation 
O -  Observation 
A - Anti tuberculuous therapy 
T -  Topical Steroids and Cycloplegics 
B - Bactrim DS 
Z -  Albendazole 
G - Ganciclovir 
Complication 
W -  Weight Gain 
G -  Gastritis 
